{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:54:34Z","timestamp":1794275674769,"version":"4.9.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To describe the clinical features, risk factors, and treatment outcomes after supratarsal injection of triamcinolone for vernal keratoconjunctivitis (VKC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective review of all patients treated with supratarsal triamcinolone for VKC between February 2002 and May 2017 at the Royal Victoria Eye and Ear Hospital and Our Lady's Children Hospital Crumlin, Dublin, Ireland, was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-five patients, 46 eyes, and 145 injections were included for analysis. The mean age at first injection was 9.1 \u00b1 5.7 years. Ninety-six percent of the patients were male. A seasonal variation was noted, with 59 injections (41%) of triamcinolone administered for acute and refractive cases of VKC in the summer compared with 35 (24%), 35 (24%), and 16 (11%) in the spring, autumn, and winter months, respectively. The most common presenting complaint was red eye, which was seen in all cases. Hay fever (64%) was the most common associated systemic disease. Each eye required, on average, 3.2 injections (range 1\u20139 injections), and the mean duration from the onset of symptoms to final treatment was 3.03 years (range 0\u20137.9 years). The mean presenting and final visual acuities were 0.33 and 0.11 logarithm of the minimum angle of resolution, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001). During our study period, no patient experienced intraocular pressure rise requiring treatment, development of lenticular opacity, or ptosis after supratarsal injection of triamcinolone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this case series, supratarsal triamcinolone was used in cases of VKC in which topical medications had failed to control the disease process. All patients reported improvement after treatment. There were no cases of intraocular pressure rise, lenticular opacity, or ptosis development after treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000001963","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:11:00Z","timestamp":1556064660000},"page":"955-958","source":"Crossref","is-referenced-by-count":6,"title":["Safety and Efficacy of Supratarsal Triamcinolone for Treatment of Vernal Keratoconjunctivitis in Ireland"],"prefix":"10.1097","volume":"38","author":[{"given":"Terence J.","family":"McSwiney","sequence":"first","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Power","sequence":"additional","affiliation":[{"name":"Sligo University Hospital, Sligo, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland;"},{"name":"Royal College of Surgeons in Ireland, Dublin, Ireland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"Brosnahan","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland;"},{"name":"Our Lady's Children Hospital Crumlin, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Power","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2011-301376","article-title":"Vernal keratoconjunctivitis: an update","volume":"97","author":"De Smedt","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-3768.2008.01347.x","article-title":"Vernal keratoconjunctivitis: a major review","volume":"87","author":"Kumar","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye (Lond)"},{"key":"R4-20230912","first-page":"9","article-title":"Tropical endemic limbo-conjunctivitis in L\u00fabumbashi, Democratic Republic of the Congo [in French]","volume":"290","author":"Chenge","year":"2003","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/0301-4738.119431","article-title":"Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India","volume":"61","author":"Saboo","year":"2013","journal-title":"Indian J Ophthalmol."},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","article-title":"A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis","volume":"107","author":"Akpek","year":"2000","journal-title":"Ophthalmology"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004397-198802840-00009","article-title":"Vernal keratoconjunctivitis","volume":"28","author":"Buckley","year":"1988","journal-title":"Int Ophthalmol Clin."},{"key":"R9-20230912","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol."},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ICO.0b013e3181cbf9d3","article-title":"Vernal keratoconjunctivitis with limbal stem cell deficiency","volume":"30","author":"Sangwan","year":"2011","journal-title":"Cornea"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res."},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2012.09.014","article-title":"Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis","volume":"155","author":"Reddy","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjo.2007.122044","article-title":"Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis","volume":"91","author":"Mantelli","year":"2007","journal-title":"Br J Ophthalmol."},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"507","DOI":"10.11622\/smedj.2015161","article-title":"Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis","volume":"57","author":"Y\u00fccel","year":"2016","journal-title":"Singapore Med J."},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ophtha.2016.11.002","article-title":"Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases","volume":"124","author":"Miyazaki","year":"2017","journal-title":"Ophthalmology"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ICO.0000000000001200","article-title":"Comparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: a randomized, double-masked study","volume":"36","author":"Zanjani","year":"2017","journal-title":"Cornea"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ICO.0b013e318030d230","article-title":"Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis","volume":"26","author":"Shen","year":"2007","journal-title":"Cornea"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","article-title":"Supratarsal injection of corticosteroid in the treatment of severe vernal keratoconjunctivitis","volume":"121","author":"Holsclaw","year":"1996","journal-title":"Am J Ophthalmol."},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5935\/0004-2749.20170045","article-title":"Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children","volume":"80","author":"Costa","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10792-011-9421-4","article-title":"Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis","volume":"32","author":"Zaouali","year":"2012","journal-title":"Int Ophthalmol."},{"key":"R21-20230912","first-page":"241","article-title":"Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis Indian","volume":"49","author":"Singh","year":"2001","journal-title":"J Ophthalmol."},{"key":"R22-20230912","first-page":"28","article-title":"Supratarsal injection of triamcinolone for vernal keratoconjunctivitis","volume":"26","author":"Qamar","year":"2010","journal-title":"Pak J Ophthalmol."},{"key":"R23-20230912","article-title":"Embolic retinal and choroidal vascular occlusion after peribulbar triamcinolone injection: a case report","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"bcr2016218908","DOI":"10.1136\/bcr-2016-218908","article-title":"Triamcinolone emboli leading to central retinal artery occlusion: a multimodal imaging study","volume":"97","author":"Gaur","year":"2017","journal-title":"BMJ Case Rep."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003226-201908000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:55:26Z","timestamp":1694544926000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201908000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000001963","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,19]]}}}